Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

NCT03839823 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

COMBINATION_PRODUCT: Docetaxel / Capecitabine
COMBINATION_PRODUCT: Capecitabine / Vinorelbine
COMBINATION_PRODUCT: Paclitaxel / Gemcitabine
DRUG: Ribociclib
DRUG: Letrozole OR Anastrozole
DRUG: Goserelin

Sponsor

Novartis Pharmaceuticals